isoxazoles has been researched along with cathepsin g in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, LS; Epp, JB; Groutas, WC; Kim, EH; Stanga, MA; Venkataraman, R; Yoder, JE | 1 |
| Bauvois, B; Laouar, A; Wietzerbin, J | 1 |
2 other study(ies) available for isoxazoles and cathepsin g
| Article | Year |
|---|---|
Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study.
Topics: Cathepsin G; Cathepsins; Humans; Isoxazoles; Kinetics; Leukocyte Elastase; Magnetic Resonance Spectroscopy; Molecular Structure; Myeloblastin; Pancreatic Elastase; Protease Inhibitors; Serine Endopeptidases; Structure-Activity Relationship | 1995 |
Protease-catalyzed conversion of insulin-like growth factor-1 and interleukin-6 into high-molecular-mass species through the sequential action of hematopoietic surface-associated cathepsin G and gamma-glutamyl transpeptidase-related activities.
Topics: 3T3 Cells; Animals; Blood Cells; Cathepsin G; Cathepsins; Cell Differentiation; Cell Division; Cells, Cultured; Endopeptidases; gamma-Glutamyltransferase; Glutathione; Guinea Pigs; Hematopoietic Stem Cells; Humans; Insulin-Like Growth Factor I; Interleukin-6; Isoxazoles; Mice; Molecular Weight; Serine Endopeptidases; Swine | 1994 |